China Universal Asset Management Company’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Buy |
|
|||||
|
2025
Q1 | $314K | Sell |
|
|||||
|
2024
Q4 | $330K | Buy |
|
|||||
|
2024
Q3 | $302K | Buy |
|
|||||
|
2024
Q2 | $150K | Sell |
|
|||||
|
2024
Q1 | $201K | Buy |
|
|||||
|
2023
Q4 | $142K | Buy |
|
|||||
|
2023
Q3 | $34.4K | Buy |
|
|||||
|
2023
Q2 | $17.4K | Sell |
|
|||||
|
2023
Q1 | $21.3K | Buy |
|
|||||
|
2022
Q4 | $21.7K | Buy |
|
|||||
|
2022
Q3 | $22K | Buy |
|